• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 17, 2021
Politics, Policy & Law

New technology add-on payments by the numbers: Data Byte

Is CMS raising the bar?
Read More
BioCentury | Jul 24, 2021
Regulation

July 23 Quick Takes: FDA wants more data from Incyte on retifanlimab

Plus: Approvals for Dalvance, Bydureon, a new PDUFA date for inclisiran and an upcoming adcomm on gene therapies 
Read More
BioCentury | Oct 19, 2015
Clinical News

Dalvance regulatory update

Read More
BioCentury | Aug 3, 2015
Company News

RaQualia, Durata Therapeutics deal

Read More
BioCentury | May 11, 2015
Clinical News

Dalvance dalbavancin: Phase III data

Read More
BioCentury | Mar 9, 2015
Clinical News

Xydalba dalbavancin regulatory update

Read More
BioCentury | Mar 3, 2015
Company News

EC approves Actavis' Xydalba for ABSSSIs

Read More
BioCentury | Feb 2, 2015
Clinical News

Xydalba dalbavancin regulatory update

Read More
BioCentury | Nov 3, 2014
Clinical News

Dalbavancin: SPA received

Read More
BioCentury | Oct 23, 2014
Cover Story

Diagnosing resistance

Read More
Items per page:
1 - 10 of 144